126 related articles for article (PubMed ID: 32229161)
21. Corrigendum to "Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasis" [Canc. Lett. 461 (2019) 65-77].
Tonucci FM; Almada E; Borini-Etichetti C; Pariani A; Hidalgo F; Rico MJ; Girardini J; Favre C; Goldenring JR; Menacho-Marquez M; Larocca MC
Cancer Lett; 2020 Mar; 473():200-201. PubMed ID: 31932121
[No Abstract] [Full Text] [Related]
22. Corrigendum to "B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells." [Canc. Lett. 375 (2016) 284-292].
Sun Y; Yang X; Liu M; Tang H
Cancer Lett; 2020 Nov; 493():16-18. PubMed ID: 32823018
[No Abstract] [Full Text] [Related]
23. Corrigendum to "Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3" [Canc Lett 379 (2016) 124-133].
Shou J; You L; Yao J; Xie J; Jing J; Jing Z; Jiang L; Sui X; Pan H; Han W
Cancer Lett; 2020 Nov; 493():13-15. PubMed ID: 32823017
[No Abstract] [Full Text] [Related]
24. Corrigendum to "FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway" [Canc. Lett. 363 (2015) 166-175].
Haque A; Rahman MA; Fuchs JR; Chen Z; Khuri FR; Shin DM; Amin ARMR
Cancer Lett; 2021 Feb; 498():249-250. PubMed ID: 33092912
[No Abstract] [Full Text] [Related]
25. Corrigendum to "Preclinical anti-cancer activity and multiple mechanisms of action of a cationic silver complex bearing N-heterocyclic carbene ligands" [Canc. Lett. 403 (2017) 98-107].
Allison SJ; Sadiq M; Baronou E; Cooper PA; Dunnill C; Georgopoulos NT; Latif A; Shepherd S; Shnyder SD; Stratford IJ; Wheelhouse RT; Willans CE; Phillips RM
Cancer Lett; 2018 Sep; 431():247. PubMed ID: 29934232
[No Abstract] [Full Text] [Related]
26. Corrigendum to "Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS study" [Canc. Lett. 487 (2020) 21-26].
Casal-Mouriño A; Ruano-Ravina A; Torres-Durán M; Parente-Lamelas I; Provencio-Pulla M; Castro-Añón O; Vidal-García I; Pena-Álvarez C; Abal-Arca J; Piñeiro-Lamas M; Fuente-Merino I; Fernández-Villar A; Abdulkader I; Valdés-Cuadrado L; Barros-Dios JM; Pérez-Ríos M
Cancer Lett; 2020 Nov; 493():10. PubMed ID: 32810636
[No Abstract] [Full Text] [Related]
27. Corrigendum to "Blocking exposed PD-L1 elicited by nanosecond pulsed electric field reverses dysfunction of CD8 + T cells in liver cancer" [Canc. Lett. 495 (2020) 1-11].
Qian J; Chen T; Wu Q; Zhou L; Zhou W; Wu L; Wang S; Lu J; Wang W; Li D; Xie H; Su R; Guo D; Liu Z; He N; Yin S; Zheng S
Cancer Lett; 2021 Feb; 498():242. PubMed ID: 33109412
[No Abstract] [Full Text] [Related]
28. Corrigendum to "Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer"[Canc. Lett. 369 (2015) 58-66].
Liu Y; Zhang X; Zhang Y; Hu Z; Yang D; Wang C; Guo M; Cai Q
Cancer Lett; 2020 Dec; 494():3-4. PubMed ID: 32827930
[No Abstract] [Full Text] [Related]
29. Corrigendum to 'ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2' [Canc. Lett. 427 (2018) 9-17].
Luo Q; Wu X; Zhang Y; Shu T; Ding F; Chen H; Zhao P; Chang W; Zhu X; Liu Z
Cancer Lett; 2021 Feb; 498():243. PubMed ID: 33342532
[No Abstract] [Full Text] [Related]
30. Corrigendum to "Caspase-independent cell death by allicin in human epithelial carcinoma cells: involvement of PKA."[Canc. Lett. (2005) 224 (1) 123-32].
Park SY; Cho SJ; Kwon HC; Lee KR; Rhee DK; Pyo S
Cancer Lett; 2019 Mar; 444():188. PubMed ID: 30528159
[No Abstract] [Full Text] [Related]
31. Corrigendum to "Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM." [Canc. Lett. 449 (2019) 31-44].
Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
Cancer Lett; 2021 Mar; 500():292-293. PubMed ID: 33390287
[No Abstract] [Full Text] [Related]
32. Corrigendum to "MLKL contributes to shikonin-induced glioma cell necroptosis via promotion of chromatinolysis" [Canc. Lett. 467 (2019) 58-71].
Ding Y; He C; Lu S; Wang X; Wang C; Wang L; Zhang J; Piao M; Chi G; Luo Y; Sai K; Ge P
Cancer Lett; 2020 Mar; 472():183. PubMed ID: 31917020
[No Abstract] [Full Text] [Related]
33. Corrigendum to "DGKA interacts with SRC/FAK to promote the metastasis of non-small cell lung cancer" [Canc. Lett. (2022 Apr 28) 532 215585].
Fu L; Deng R; Huang Y; Yang X; Jiang N; Zhou J; Lin C; Chen S; Wu L; Cui Q; Yun J
Cancer Lett; 2022 Jul; 539():215696. PubMed ID: 35477591
[No Abstract] [Full Text] [Related]
34. Corrigendum to "Long non-coding RNA Unigene 56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells" [Canc. Lett. 382 (2016) 166-175].
Lv J; Fan HX; Zhao XP; Lv P; Fan JY; Zhang Y; Liu M; Tang H
Cancer Lett; 2020 Mar; 472():181-182. PubMed ID: 31879079
[No Abstract] [Full Text] [Related]
35. Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71-80].
Wang LL; Jin XH; Cai MY; Li HG; Chen JW; Wang FW; Wang CY; Hu WW; Liu F; Xie D
Cancer Lett; 2022 Jul; 539():215700. PubMed ID: 35525812
[No Abstract] [Full Text] [Related]
36. Corrigendum to "Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages" [Canc. Lett. 474 (2020) 36-52].
Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X
Cancer Lett; 2022 Jan; 525():200-202. PubMed ID: 34785089
[No Abstract] [Full Text] [Related]
37. Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Canc. Lett. 337 (2013) 226-236].
Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Chen J; Su C
Cancer Lett; 2020 Mar; 473():198-199. PubMed ID: 31926781
[No Abstract] [Full Text] [Related]
38. Corrigendum to "miR-346 functions as a pro-survival factor under ER stress by activating mitophagy" [Canc. Lett. 413 (2018) 69-81].
Guo J; Yang Z; Yang X; Li T; Liu M; Tang H
Cancer Lett; 2020 Nov; 493():11-12. PubMed ID: 32810637
[No Abstract] [Full Text] [Related]
39. Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].
Moskovich D; Alfandari A; Finkelshtein Y; Weisz A; Katzav A; Kidron D; Edelstein E; Veroslavski D; Perets R; Arbib N; Kadan Y; Fishman A; Lerer B; Ellis M; Ashur-Fabian O
Cancer Lett; 2023 Jun; 563():216196. PubMed ID: 37104919
[No Abstract] [Full Text] [Related]
40. Corrigendum to "Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells" [Canc. Lett. 469 (2020) 498-509].
Yuan P; Yang T; Mu J; Zhao J; Yang Y; Yan Z; Hou Y; Chen C; Xing J; Zhang H; Li J
Cancer Lett; 2021 Nov; 521():322-323. PubMed ID: 34521548
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]